https://wikimd.org/index.php?action=history&feed=atom&title=ClocinnamoxClocinnamox - Revision history2026-04-25T23:52:55ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.org/index.php?title=Clocinnamox&diff=5805668&oldid=prevPrab: CSV import2024-05-22T15:26:53Z<p>CSV import</p>
<p><b>New page</b></p><div>[[File:Clocinnamox.svg|thumb|Clocinnamox.svg]] '''Clocinnamox''' is a [[synthetic]] [[opioid]] [[antagonist]] that is used in [[scientific research]] to study the [[opioid receptor]] system. It is particularly known for its ability to selectively and irreversibly block the [[mu-opioid receptor]] (MOR), which is one of the three main types of opioid receptors, the others being the [[delta-opioid receptor]] (DOR) and the [[kappa-opioid receptor]] (KOR).<br />
<br />
==Chemical Structure and Properties==<br />
Clocinnamox belongs to the class of [[4-phenylpiperidine]] derivatives. Its chemical structure is characterized by the presence of a [[phenyl]] ring and a [[piperidine]] ring, which are essential for its binding affinity to the mu-opioid receptor. The irreversible binding of clocinnamox to the MOR is due to its ability to form a covalent bond with the receptor, leading to long-lasting antagonistic effects.<br />
<br />
==Mechanism of Action==<br />
Clocinnamox acts by binding irreversibly to the mu-opioid receptor, thereby preventing the activation of the receptor by endogenous [[opioid peptides]] such as [[endorphins]] and [[enkephalins]], as well as exogenous opioid drugs like [[morphine]] and [[heroin]]. This irreversible binding results in a prolonged blockade of the receptor, making clocinnamox a valuable tool in opioid research for studying the long-term effects of opioid receptor inhibition.<br />
<br />
==Research Applications==<br />
Clocinnamox is primarily used in [[preclinical research]] to investigate the role of the mu-opioid receptor in various physiological and pathological processes. It has been employed in studies examining [[pain management]], [[addiction]], and [[tolerance]] to opioid drugs. By irreversibly blocking the mu-opioid receptor, researchers can better understand the receptor's function and its involvement in opioid-related behaviors.<br />
<br />
==Pharmacokinetics==<br />
The pharmacokinetics of clocinnamox involve its absorption, distribution, metabolism, and excretion. Due to its irreversible binding to the mu-opioid receptor, the duration of its antagonistic effects is significantly longer compared to reversible opioid antagonists like [[naloxone]] and [[naltrexone]]. This makes clocinnamox particularly useful for long-term studies on opioid receptor function.<br />
<br />
==Safety and Toxicity==<br />
As with other opioid antagonists, the safety and toxicity profile of clocinnamox must be carefully considered in research settings. While it is not used clinically, its effects on the opioid system can provide insights into the potential risks and benefits of opioid receptor modulation.<br />
<br />
==See Also==<br />
* [[Opioid receptor]]<br />
* [[Mu-opioid receptor]]<br />
* [[Delta-opioid receptor]]<br />
* [[Kappa-opioid receptor]]<br />
* [[Opioid antagonist]]<br />
* [[Naloxone]]<br />
* [[Naltrexone]]<br />
* [[Endorphins]]<br />
* [[Enkephalins]]<br />
<br />
==References==<br />
{{Reflist}}<br />
<br />
==External Links==<br />
{{Commons category|Clocinnamox}}<br />
<br />
[[Category:Opioid antagonists]]<br />
[[Category:Pharmacology]]<br />
[[Category:Research chemicals]]<br />
[[Category:4-Phenylpiperidines]]<br />
<br />
{{medicine-stub}}</div>Prab